Anti-cancer selection as a source of developmental and evolutionary constraints

BioEssays

Volumn 25, Issue 11, 2003, Pages 1035-1039

  Galis, Frietson ^a   Metz, Johan A J ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b INTERNATIONAL INSTITUTE FOR APPLIED SYSTEMS ANALYSIS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER RISK; GENETIC LINKAGE; GENETIC SELECTION; MOLECULAR EVOLUTION; PREVALENCE; REVIEW;

ABNORMALITIES; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; EVOLUTION; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 0242551399     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10366     Document Type: Review

References (41)

1. Leroi AM, Koufopanou V, Burt A. Cancer selection. Nature Rev Cancer 2003;3:226-231.
2. Kavanagh KD. Embedded molecular switches, anticancer selection, and effects on ontogenetic rates: a hypothesis of developmental constraint on morphogenesis and evolution. Evolution 2003;57:939-948.
3. Galis F. Why do almost all mammals have seven cervical vertebrae? Developmental constraints, Hox genes and Cancer. J Exp Zool (Mol Dev Evol) 1999;285:19-26.
4. Galis F. On the homology of structures and Hox genes: the vertebral column. Novartis Foundation Symposium 1999;222:80-94.
5. Margulis L. Symbiosis and cell evolution. San Francisco: Freeman. 1981.
6. Buss LW. The evolution of individuality. Princeton: Princeton Univ. Press. 1987.
7. Grüneberg H. The Pathology of Development. A Study of inherited skeletal Disorders in Animals, Oxford: Blackwell Scientific. 1963.
8. Zuzarte-Luís V, Hurlé JM. Programmed cell death in the developing limb. Int J Dev Biol 2002;46:871-876.
9. Graham J. Cancer Selection: the new theory of evolution, Lexington: Aculeus. 1992.
10. Tjalma RA. Canine bone sarcoma: estimation of relative risk as function of body size. J Natl Cancer Inst 1966;36:1137-1150.
11. Withrow SJ, Powers BE, Straw RC, Wilkins RM. Comparative aspects of osteosarcoma: dog versus man. Clin Orthop 1991;270:159-168.
12. th edition. Philadelphia: Lippincott Williams and Wilkins. 2002.
13. Vanasse GJ, Concannon P, Willerford DM. Regulated genomic instabililty and neoplasia in the lymphoid lineage. Blood 1999;94:3997-4010.
14. Summers K, Da Silva J, Farwell MA. Intragenomic conflict and cancer. Medical Hypotheses 2002;59:170-179.
15. Wilkins JF, Haig D. What good is genomic imprinting: the function of parent-specific gene expression. Nature Rev Genet 2003;4:1-10.
16. O'Neill MJ, Ingram RS, Vrana PB, Tilgham SM. Allelic expression for IGF2 in marsupials and birds. Dev Genes Evol 2000;210:18-20.
17. Wu HK, Weksberg R, Minden MD, Squire JA. Loss of imprinting of human insulin-like growth factor II, IGF2, in acute myeloid leukemia. Biochem Biophys Res Commun 1997;231:466-472.
18. Houtenbos I, Ossenkoppele GJ. Acute myeloid leukemia in a 23-year-old patient with Beckwith-Wiedemann syndrome. Cancer Genet Cytogenet 2002;136:90-91.
19. Schumacher R, Mai A, Gutjahr P. Association of rib anamalies and malignancy in childhood. Eur J Pediatr 1992;151:432-434.
20. Dawe CJ. Phylogeny and oncogeny. Natl Cancer Instit Monogr 1969;31:1-40.
21. Effron M, Griner L, Benirschke K. Nature and rate of neoplasia in captive wild mammals, birds and reptiles at necropsy. J Nat Cancer Int 1977;59:185-198.
22. Fox H. Observations upon neoplasms in wild animals in the Philadelphia Zoological Gardens. J Path Bact 1912;17:217-231.
23. Lombard LS, Witte EJ. Frequency and types of tumors in mammals and birds of the Philadelphia Zoological Garden. Cancer Res 1959:19:127-141.
24. Zwart P, Harshbarger JC. Hematopoietic neoplasms in lizards: report of a typical case in Hydrosaurus amboinensis and a probable case in Varanus savator. Int J Cancer 1972;9:548-553.
25. Ramsay EC, Munson L, Lowenstine L, Fowler ME. A retrospective study of neoplasia in a collection of captive snakes. J Zoo Wild Medicine 1996;27:28-34.
26. Ratcliffe HL. Incidence and nature of tumors in captive wild mammals and birds. Am J Cancer 1933;17:116-135.
27. McNab BK. Energetics, body size, and the limits to endothermy. J Zool Lond 1983;199:1-29.
28. Gallivan GJ, Best RC. Metabolism and respiration of the amazonian manatee (Trichechus inunguis). Physiol Zool 1980;53:245-253.
29. Koteja P. On the relation between basal and field metabolic rates in birds and mammals. Funct Ecol 1999;5:56-64.
30. Hammond KA, Diamond J. Maximal sustained energy budgets in humans and animals. Nature 1997;386:457-462.
31. Shigenaga MK, Ames BN. 1993. Oxidants and mitogenesis as causes of mutation and cancer: the influence of diet. In Bronzetti G, et al. editors. Antimutagenesis and Anticarcinogenesis mechanisms III. New York: Plenum Press. pp 419-436.
32. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 1997;60:474-485.
33. Kobayashi N, Furukawa T, Takatsu T. Congenital anomalies in children with malignancy. Paediatr Univ Tokyo 1968;16:31-37.
34. Nakissa N, Constine LS, Rubin P, Strohl R. Birth defects in three common pediatric malignancies; Wilms' tumor, neuroblastoma and Ewing's Sarcoma. Oncology 1985;42:358-363.
35. Alter BP. Arms and the man or hands and the child: congenital anomalies and hematologic syndromes. J Pediat Hematol/Oncol 1997;19:287-291.
36. Lande R. Evolutionary mechanisms of limb loss in tetrapods. Evolution 1978;32:73-92.
37. Galis F, Van Alphen JJM, Metz JAJ. Why five fingers? Evolutionary constraints on digit numbers. Trends Ecol Evol 2001;16:637-646.
38. Amundson R. Two concepts of constraint: adaptationism and the challenge from developmental biology. Phil Sci 1994;61:556-578.
39. Arthur W. Developmental constraint and natural selection. Evol Dev 2003;5:117-118.
40. Beldade P, Brakefield PM. The difficulty of agreeing about constraints. Evol Dev 2003;5:119-120.
41. Schwenk K, Wagner GP. 2003. Constraint. In Hall BK, Olson WM, editors. Keywords and concepts in evolutionary developmental biology. Cambridge MA: Harvard Univ. Press. pp 52-61.